Interactions between cAMP- and cGMP-dependent protein kinase inhibitors and phosphodiesterase IV inhibitors on arachidonate release from human monocytes

Life Sciences

Volumn 59, Issue 16, 1996, Pages PL255-PL261

  Hichami, A ^a   Boichot, E ^a   Germain, N ^a   Coqueret, O ^b   Lagente, Vincent ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

arachidonate; monocytes; phosphodiesterase; protein kinase

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ARACHIDONIC ACID; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DERIVATIVE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN KINASE INHIBITOR; RADIOISOTOPE; ROLIPRAM;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN;

EID: 0030582462     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00464-x     Document Type: Article

References (20)

1. 1. NICHOLSON, C.D. and M. SHAHID. Pulm. Pharmacol. 7 1-17 (1994).
2. 2. COQUERET, O., D. DEMARQUAY and V. LAGENTE. Eur. Respir. J. 9 220-225 (1996).
3. 3. BEAVO, J.A. and D.K. REIFSNYDER. Trends Pharmacol. Sci. 11 150-155 (1990).
4. 4. BEAVO, J.A., M. CONTI and R.J. HEASLIP. Mol. Pharmacol. 46 399-405 (1994).
5. 5. LINCOLN, T.M. and J.D. CORBIN. Adv. Cyclic Nucleotide Res. 15 139-192 (1983).
6. 6. BEAVO, J.A., P.J. BECHTEL and E.G. KREBS. Proc. Natl. Acad. Sci. (USA) 71 3580-3583 (1974).
7. 7. JIANG, H., J.B. SHABB and J.D. CORBIN. Biochem. Cell Biol. 70 1283-1289 (1992).
8. 8. HICHAMI, A., E. BOICHOT, N. GERMAIN, A. Legrand, I. Moodley and V. Lagente. Eur. J. Pharmacol.-Mol. Pharmacol. section 291 91-97 (1995).
9. 9. HIDAKA, H., M. INAGAKI, S. KAWAMOTO and Y. SASAKI. Biochemistry 23 5036-5041 (1984)
10. 10. CHIJIWA, T., A. MISHIMA, M. HAGIWARA, M. SANO, K. HAYASHI, T. INOUE, K. NAITO, T. TOSHIOKA and H. HIDAKA, J. Biol. Chem. 265 5267-5272 (1990).
11. 11. BUTT, E., M. EIGENTHALER and H.G. GENIESER. Eur. J. Pharmacol.-Mol. Pharmacol. section 269 265-268 (1994).
12. 12. SCHMIDT, H.H., S.M. LOHMANN and U. WALTER. Biochem. Biophys. Acta 1178 153-175 (1993).
13. 13. FRANCIS, S.H. and J.D. CORBIN. Annu. Rev. Physiol. 56 237-272 (1994).
14. 14. TORPHY, T.J., W. FREESE, G.A. RINARD, L.L. BRUNTON and S.E. MAYER. J. Biol. Chem. 257 11609-11616 (1982).
15. 15. JIANG, H., J.L. COLBRAN, S.H. FRANCIS and J.D. CORBIN. J. Biol. Chem. 267 1015-1019 (1992).
16. 16. LINCOLN, T.M., T.L. CORNWELL and A.E. TAYLOR. Am. J. Physiol. 258 C399-C407 (1990).
17. 17. ECKLY, A.E., J.C. STOCLET and C. LUGNIER. Br. J. Pharmacol. 114 206P (1995).
18. 18. SENE, D.C., A. BIELAWSKA, C.S. GREENBERG and Y.A. HANNUN. Biochem. Biophys. Res. Commun. 165 708-714 (1989).
19. 19. BUTT, E, C. NOLTE, S. SCHULZ, J. BELTMAN, J.A. BEAVO, B. JASTORFF and U. WALTER. Biochem Pharmacol. 43 2591-2600 (1992).
20. 20. HALLSWORTH, MP, MA GIEMBYCZ, P.J. BARNES and T.H. LEE. Br. J. Pharmacol. 117 79-86 (1996).